Thomas F. Babcock, D.O.’88, Ph.D.

Thomas Babcock, D.O.’88, Ph.D., was among the authors of the article “Aiming for remission in adults with attention-deficit/hyperactivity disorder: the primary care goal,” published in February in Postgraduate Education. He is associate director of scientific publications, medical affairs, with Shire Pharmaceuticals in Wayne, PA.

Leave a Reply

Comments